Free Trial

The Procter & Gamble Company (NYSE:PG) is Windle Wealth LLC's 7th Largest Position

Procter & Gamble logo with Consumer Staples background
Remove Ads

Windle Wealth LLC raised its holdings in shares of The Procter & Gamble Company (NYSE:PG - Free Report) by 3.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 47,785 shares of the company's stock after buying an additional 1,583 shares during the period. Procter & Gamble comprises 4.4% of Windle Wealth LLC's portfolio, making the stock its 7th largest holding. Windle Wealth LLC's holdings in Procter & Gamble were worth $8,011,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Geode Capital Management LLC increased its holdings in Procter & Gamble by 7.0% during the third quarter. Geode Capital Management LLC now owns 55,204,776 shares of the company's stock valued at $9,538,327,000 after buying an additional 3,619,466 shares during the last quarter. FMR LLC boosted its position in shares of Procter & Gamble by 2.7% in the third quarter. FMR LLC now owns 26,556,319 shares of the company's stock worth $4,599,554,000 after purchasing an additional 689,282 shares during the period. Franklin Resources Inc. boosted its position in shares of Procter & Gamble by 10.2% in the third quarter. Franklin Resources Inc. now owns 18,988,721 shares of the company's stock worth $3,290,573,000 after purchasing an additional 1,760,214 shares during the period. Fisher Asset Management LLC boosted its position in shares of Procter & Gamble by 1.7% in the fourth quarter. Fisher Asset Management LLC now owns 18,692,813 shares of the company's stock worth $3,133,850,000 after purchasing an additional 312,203 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its position in shares of Procter & Gamble by 2.8% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 16,881,907 shares of the company's stock worth $2,830,252,000 after purchasing an additional 459,437 shares during the period. 65.77% of the stock is owned by hedge funds and other institutional investors.

Procter & Gamble Trading Down 1.8 %

Shares of PG opened at $173.07 on Wednesday. The Procter & Gamble Company has a twelve month low of $153.52 and a twelve month high of $180.43. The company has a market cap of $405.83 billion, a P/E ratio of 27.56, a P/E/G ratio of 3.76 and a beta of 0.41. The company has a current ratio of 0.76, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The company's fifty day simple moving average is $167.14 and its 200-day simple moving average is $169.84.

Remove Ads

Procter & Gamble (NYSE:PG - Get Free Report) last announced its earnings results on Wednesday, January 22nd. The company reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.86 by $0.02. Procter & Gamble had a net margin of 18.35% and a return on equity of 33.00%. The business had revenue of $21.88 billion for the quarter, compared to the consensus estimate of $21.66 billion. During the same quarter in the prior year, the firm posted $1.84 earnings per share. The business's revenue for the quarter was up 2.1% on a year-over-year basis. As a group, analysts expect that The Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, February 18th. Investors of record on Friday, January 24th were paid a $1.0065 dividend. This represents a $4.03 annualized dividend and a yield of 2.33%. The ex-dividend date of this dividend was Friday, January 24th. Procter & Gamble's dividend payout ratio is presently 64.01%.

Insider Buying and Selling

In related news, insider Marc S. Pritchard sold 90,450 shares of the firm's stock in a transaction dated Thursday, January 23rd. The shares were sold at an average price of $163.84, for a total value of $14,819,328.00. Following the transaction, the insider now owns 172,814 shares of the company's stock, valued at $28,313,845.76. This trade represents a 34.36 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Gary A. Coombe sold 35,000 shares of the stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $173.68, for a total transaction of $6,078,800.00. Following the transaction, the chief executive officer now owns 22,051 shares in the company, valued at approximately $3,829,817.68. The trade was a 61.35 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 143,450 shares of company stock valued at $23,988,008 in the last 90 days. Company insiders own 0.18% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on PG. JPMorgan Chase & Co. dropped their price target on shares of Procter & Gamble from $186.00 to $181.00 and set an "overweight" rating for the company in a research report on Thursday, January 16th. Royal Bank of Canada reiterated a "sector perform" rating and issued a $164.00 price target on shares of Procter & Gamble in a research report on Thursday, January 23rd. UBS Group reiterated a "buy" rating on shares of Procter & Gamble in a research report on Monday, February 10th. Wells Fargo & Company upped their price target on shares of Procter & Gamble from $176.00 to $180.00 and gave the stock an "overweight" rating in a research report on Thursday, January 23rd. Finally, Piper Sandler dropped their price target on shares of Procter & Gamble from $173.00 to $172.00 and set a "neutral" rating for the company in a research report on Monday, February 24th. Seven equities research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, Procter & Gamble currently has an average rating of "Moderate Buy" and an average target price of $181.47.

View Our Latest Research Report on PG

About Procter & Gamble

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Recommended Stories

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

7 Stocks to Benefit From Trump’s Tariffs in 2025

7 Stocks to Benefit From Trump’s Tariffs in 2025

While the impact of these tariffs remains uncertain, some stocks are positioned to thrive under these policies; check out these 7 stock picks now.

Recent Videos

Best ETFs for Spring 2025: Strong and Steady Investing
Is There Still Money in AI? How to Invest in the Next Big Wave
AMD at Rock Bottom? Analysts Predict a MAJOR Rebound!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads